💨 Abstract

Donald Trump announced plans to slash US drug prices to the lowest global rates, impacting British firms AstraZeneca and GSK, which rely heavily on the US market. The "favored nation" policy aims to reduce prices by 60-90%. Despite initial share drops, details were vague, focusing on pharmacy managers and insurers. Trump will set price targets in 30 days and use federal powers if progress is slow.

Courtesy: www.thesun.co.uk

Summarized by Einstein Beta 🤖

Powered by MessengerX.io